The effect of
manidipine on
cardiac hypertrophy, coronary circulation, left ventricular weight and maximal coronary flow in
hypertension was measured in
DOCA/
salt treated systolic hypertensive rats with and without
manidipine treatment. Normotensive rats were used as controls. After feeding with 0.05%
manidipine-containing food, blood pressure was reduced only in
DOCA/
salt hypertensive rats, but not in control rats. After 3 weeks of treatment,
sodium excretion was significantly increased in
DOCA/
salt-treated rats with or without
manidipine treatment. Hearts were removed and perfused with modified
Krebs-Henseleit solution with
adenosine (5 x 10(-5) M) in a Langendorff apparatus. Maximal coronary flow (MCF) was significantly decreased only in
DOCA/
salt hypertensive rats without treatment, while
manidipine treatment restored MCF. Left ventricular
weight/body weight was also markedly greater in
DOCA/
salt-treated rats not given
manidipine. Left ventricular weight in
DOCA/
salt-treated rats given
manidipine was significantly reduced compared with
DOCA/
salt hypertensive rats without treatment, although it was heavier than in the control animals. Morphological examination showed that the increased wall/lumen ratio in
DOCA/
salt hypertensive rats was reduced by
manidipine treatment. These findings suggest that treatment with
manidipine in
DOCA/
salt hypertensive rats lowered
high blood pressure and improved impaired coronary circulation with a reduction in left ventricular and vascular
hypertrophy.